JOSHUA D REMICK

Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology PORTLAND, OR NPI 1861697682

General Payments — all program years on this page

$112,521.50

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 209
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $20,369.55 across 27 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $14,963.2814
Lilly USA, LLC $4,701.415
Ancora Heart, Inc. $344.821
CVRx Inc. $221.423
IMPULSE DYNAMICS (USA) INC. $93.252
ABIOMED $31.431
Abbott Laboratories $13.941

By program year

Program yearAmountRecords
2018 $800.7710
2019 $678.7515
2020 $57.973
2021 $261.885
2022 $42,555.8852
2023 $47,796.7097
2024 $20,369.5527

Records — PY2024 (27)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1073585679 Ancora Heart, Inc. $344.82 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100423629 Impulse Dynamics (USA) Inc. $46.02 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100423633 Impulse Dynamics (USA) Inc. $47.23 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196678 Boehringer Ingelheim Pharmaceuticals, Inc. $28.79 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196682 Boehringer Ingelheim Pharmaceuticals, Inc. $97.39 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196686 Boehringer Ingelheim Pharmaceuticals, Inc. $109.98 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196690 Boehringer Ingelheim Pharmaceuticals, Inc. $115.39 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196694 Boehringer Ingelheim Pharmaceuticals, Inc. $122.47 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196698 Boehringer Ingelheim Pharmaceuticals, Inc. $146.81 02/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196702 Boehringer Ingelheim Pharmaceuticals, Inc. $178.64 02/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118196706 Boehringer Ingelheim Pharmaceuticals, Inc. $280.12 02/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118196710 Boehringer Ingelheim Pharmaceuticals, Inc. $1,358.69 03/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118196714 Boehringer Ingelheim Pharmaceuticals, Inc. $1,750.00 05/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118196718 Boehringer Ingelheim Pharmaceuticals, Inc. $2,425.00 04/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118196722 Boehringer Ingelheim Pharmaceuticals, Inc. $2,425.00 09/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118196726 Boehringer Ingelheim Pharmaceuticals, Inc. $2,850.00 04/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118196730 Boehringer Ingelheim Pharmaceuticals, Inc. $3,075.00 01/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1125310234 Abbott Laboratories $13.94 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135088563 Lilly USA, LLC $48.00 02/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135096106 Lilly USA, LLC $30.79 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135105879 Lilly USA, LLC $880.00 07/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1135107291 Lilly USA, LLC $3,740.00 02/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1135109586 Lilly USA, LLC $2.62 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138420044 CVRx, Inc. $159.91 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138420046 CVRx, Inc. $27.13 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138420048 CVRx, Inc. $34.38 07/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1142214873 ABIOMED $31.43 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.